ArticleFrontiers in cardiovascular medicine2022

Pirfenidone Has Anti-fibrotic Effects in a Tissue-Engineered Model of Human Cardiac Fibrosis.

Thomas C L Bracco Gartner et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.